ArchiMed scores 300x return for debut fund with Polyplus exit

ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €‎2.4bn.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.